Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder (vol 159, pg 394, 1998)

被引：0
|
作者：
Stampfer, DS
Carpinito, GA
RodriguezVillanueva, J
Willsey, LW
Dinney, CP
Grossman, HB
Fritsche, HA
McDougal, WS
机构：
来源：
JOURNAL OF UROLOGY | 1998年 / 159卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：1650 / 1650
页数：1
相关论文
共 50 条
  • [1] Evaluation of NMP22 in the detection of transitional cell carcinoma of the bladder
    Stampfer, DS
    Carpinito, GA
    Rodriguez-Villanueva, J
    Willsey, LW
    Dinney, CP
    Grossman, HB
    Fritsche, HA
    McDougal, WS
    JOURNAL OF UROLOGY, 1998, 159 (02): : 394 - 398
  • [2] Clinical application of NMP22 in the management of transitional cell carcinoma of the bladder
    Sawczuk, IS
    Bagiella, E
    Sawczuk, AT
    Yun, EJ
    CANCER DETECTION AND PREVENTION, 2000, 24 (04): : 364 - 368
  • [3] BTA quantitative assay and NMP22 testing compared with urine cytology in the detection of transitional cell carcinoma of the bladder
    Casetta, G
    Gontero, P
    Zitella, A
    Pelucelli, G
    Formiconi, A
    Priolo, G
    Martinasso, G
    Mengozzi, G
    Aimo, G
    Viberti, L
    Tizzani, A
    UROLOGIA INTERNATIONALIS, 2000, 65 (02) : 100 - 105
  • [4] Evaluation of the clinical value of urinary NMP22 as a marker in the screening and surveillance of transitional cell carcinoma of the urinary bladder
    Chahal, R
    Darshane, A
    Browning, AJ
    Sundaram, SK
    EUROPEAN UROLOGY, 2001, 40 (04) : 415 - 420
  • [5] Evaluation of the clinical value of urinary NMP22 as a marker in the surveillance of superficial transitional cell carcinoma of the urinary bladder
    Janjic, A.
    Lalic, N.
    Glisic, B.
    Jovanovic, M.
    Bojanic, N.
    Micic, S.
    EUROPEAN UROLOGY SUPPLEMENTS, 2009, 8 (08) : 607 - 607
  • [6] Urinary NMP22 for the detection of recurrence after transurethral resection of transitional cell carcinoma of the bladder: Experience on 137 patients
    Serretta, V
    Presti, DL
    Vasile, P
    Gange, E
    Esposito, E
    Menozzi, I
    UROLOGY, 1998, 52 (05) : 793 - 796
  • [7] Evaluation of the clinical value of urinary NMP22 as a marker in the screening and surveillance of transitional cell carcinoma of the urinary bladder - Editorial comment
    Witjes, F
    EUROPEAN UROLOGY, 2001, 40 (04) : 421 - 421
  • [8] Urinary nuclear matrix protein 22 (NMP22): A diagnostic adjunct to urine cytologic examination for the detection of recurrent transitional-cell carcinoma of the bladder
    Hughes, JH
    Katz, RL
    Rodriguez-Villanueva, J
    Kidd, L
    Dinney, C
    Grossman, HB
    Fritsche, HA
    DIAGNOSTIC CYTOPATHOLOGY, 1999, 20 (05) : 285 - 290
  • [9] Patients with a negative cystoscopy and negative Nmp22® Bladderchek® test are at low risk of missed transitional cell carcinoma of the bladder: a prospective evaluation
    Terrell, John D.
    Elias, Keren J.
    Sagalowsky, Arthur I.
    Lotan, Yair
    INTERNATIONAL BRAZ J UROL, 2011, 37 (06): : 706 - 711
  • [10] Urinary NMP22 and renal cell carcinoma
    Huang, S
    Rhee, E
    Patel, M
    Park, E
    Kaswick, J
    UROLOGY, 2000, 55 (02) : 227 - 230
12345